MAPT and Alzheimer disease: In contrast, AD-treated conditions showed a wider range of DEG counts, from as few as 2 in AD5 to as many as 581 in AD1, indicating a substantial variation in gene expression responses to spiking of cells with AD tau aggregates, which may relate to specific post-translational modifications of tau.